MAZ and neoplasm: Mechanistically, transcription factor p110 CUX1, a proteolytic product of p200 CUX1, promotes expression of glycolytic genes, while circ‐CUX1 facilitates EWSR1‐mediated MAZ transactivation to alter expression of p200 CUX1 and other genes associated with tumor progression.